Vynleads

Vynleads EBITDA per Share

The EBITDA per Share of Vynleads (VYND) as of Oct 23, 2026 is -0.01 USD. In the previous year, EBITDA per Share was -0.01 USD — a change of 3.38% (lower).

EBITDA per Share

-0.01USD

YoY

3.38%

Last updated:

EBITDA per Share of Vynleads is 2025 -0.01 USD. EBITDA per Share of Vynleads was 2024 -0.01 USD. It decreases by 3.38% lower compared to the previous year.

The Vynleads EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.05 USD
Jan 1, 2019
-0.03 USD
Jan 1, 2020
-0.03 USD
Jan 1, 2021
-0.02 USD
Jan 1, 2022
-0.02 USD
Jan 1, 2023
-0.02 USD
Jan 1, 2024
-0.01 USD
Jan 1, 2025
-0.01 USD
The Vynleads EBITDA per Share history
YEAREBITDA per ShareYoY
-0.01USD+3.38%
-0.01USD-35.76%
-0.02USD-9.77%
-0.02USD-2.07%
-0.02USD-27.96%
-0.03USD+21.87%
-0.03USD-42.47%
-0.05USD+17.16%
-0.04USD-1,986.23%
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vynleads Stock analysis

What does Vynleads do? Vynleads, Inc. generates revenue through the sale of digital guides and nutritional supplements targeting individuals managing type-2 diabetes and pre-diabetes. The company offers The DWD Protocol: Success Blueprint, a digital guide featuring dietary recommendations for a very low calorie eight-week diet, along with modules like The Foundation, The Meal Plan, Diabetes Free Lifestyle, and Taking Control, complemented by recipe books. Additionally, Vynleads sells DWDx3 Advanced Daily Supplement and Premium-Grade Omegax3, which are nutritional supplements designed to support users' health goals. Its primary customers are families seeking natural solutions for diabetes management, who purchase these products to access structured dietary plans and supplement regimens. The company’s products are positioned as educational resources that provide clear, generic blueprints for healthy living, appealing to customers focused on making informed dietary choices. The Lifestyle Blueprint modules and recipe books serve as complementary materials to the core digital guide, enhancing user engagement with the dietary system. Nutritional supplements are sold alongside the digital content, creating a bundled offering that addresses both dietary and nutritional needs for diabetes prevention and control. Vynleads targets customers actively managing type-2 diabetes or pre-diabetes through natural methods, leveraging its digital guide and supplement line to deliver comprehensive solutions. The company’s revenue streams are derived from direct sales of The DWD Protocol: Success Blueprint, its associated modules, recipe books, and the two supplement products, all designed to support users in achieving healthier lifestyles without medical intervention. Vynleads is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vynleads stock

EBITDA per Share of Vynleads is -0.01 USD in 2025.

EBITDA per Share of Vynleads changed from -0.01 USD to -0.01 USD, representing a 3.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Vynleads since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Vynleads

All Key Metrics — Vynleads